Larimar Therapeutics (ZA71) Q2 2024 Earnings Report
DE:ZA71 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.30
- Consensus EPS
- -EUR 0.27
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.17
DE:ZA71 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 7, 2024
DE:ZA71 Upcoming Earnings
Larimar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ZA71 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.31- | -0.55 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -0.34-0.27 | -0.37 | 26.83% (+0.10) | |
| May 14, 2026 | 2026 (Q1) | -0.48-0.28 | -0.41 | 32.61% (+0.13) | |
| Mar 19, 2026 | 2025 (Q4) | -0.44-0.65 | -0.4 | -62.22% (-0.25) | |
| Nov 05, 2025 | 2025 (Q3) | -0.36-0.55 | -0.21 | -154.17% (-0.33) | |
| Aug 14, 2025 | 2025 (Q2) | -0.43-0.37 | -0.3 | -20.59% (-0.06) | |
| Apr 30, 2025 | 2025 (Q1) | -0.37-0.41 | -0.24 | -70.37% (-0.17) | |
| Mar 24, 2025 | 2024 (Q4) | -0.28-0.40 | -0.27 | -50.00% (-0.13) | |
| Oct 30, 2024 | 2024 (Q3) | -0.34-0.21 | -0.19 | -14.29% (-0.03) | |
| Aug 07, 2024 | 2024 (Q2) | -0.27-0.30 | -0.17 | -78.95% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
